Royal DSM and Lallemand reach joint license agreement
In the United States (US), Royal DSM, a Netherlands-headed global science-based company active in health, nutrition, and materials and Lallemand Inc. have announced a joint agreement under which DSM grants to Lallemand a non-exclusive, royalty-bearing license to DSM’s low-glycerol yeast technology patents (US Patent No. 8,795,998).
The license agreement is part of a settlement that was reached following a 2018 US Federal Court jury verdict in Wisconsin. The referenced technology in the agreement is for use in the fermentation of first-generation biofuels.
A privately-held Canadian company, Lallemand Inc., through its Lallemand Biofuels & Distilled Spirits (LBDS) business unit, is a leading company specializing in the research, development, production, marketing and distribution of yeast, bacteria and other microorganisms for use in the food ingredient, human nutrition, animal nutrition, baking, wine, beer, distilled spirits, biofuels, plant care, cosmetic and pharmaceutical industries.